Find policies, billing codes, payers, states, and providers
CPT 81112: HPA-15 (S682Y) Genetic Analysis
CPT code 81112 covers the technical laboratory analysis of the two common alleles of Human Platelet Antigen 15 (HPA–15/S682Y) using specimens such as blood or amniotic fluid. This targeted genetic test is clinically relevant for platelet alloimmunization assessment, transfusion compatibility evaluation, and prenatal diagnostic considerations, making it an important assay in hematology, transfusion medicine, and maternal-fetal medicine. Nationally, molecular platelet antigen testing can affect blood bank operations, prenatal care workflows, and genetic counseling referrals.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for HPA–15 testing, typical sites of service and workflow implications, common modifier usage and billing considerations where applicable, and an outline of payer coverage patterns when available. The publication also provides benchmarking and policy-relevant notes to aid coding accuracy and payer communications. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 81112 policy alerts
Get alerted when payer policies referencing 81112 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 81112 describes a molecular diagnostic laboratory test that analyzes the genes encoding the two common alleles of Human Platelet Antigen 15 (HPA–15), also called S682Y. The procedure involves a laboratory analyst performing the technical component of the genetic assay on an appropriate specimen, such as blood or amniotic fluid.
-
Service type: Genetic laboratory testing / molecular diagnostic analysis
-
Typical site of service: Clinical laboratory or hospital-based laboratory using blood draw or amniotic fluid specimen